Large visions make small uncertainties difficult to see.
A founder can describe autonomous factories, programmable biology, sovereign semiconductors, abundant clean energy or a new space economy. Each future may be directionally plausible. None tells me what can kill the company in the next eighteen months.
I have learned to remove the category words from the pitch.
Remove AI, quantum, space, climate, autonomy and national security. Remove the market-size slide and the eventual platform. Then ask:
What result, if it remains below the required threshold, makes the rest of the story irrelevant?
That is the death variable.
It is the smallest decisive uncertainty capable of ending the company even if the larger vision is correct.
The death variable turns a story into an experiment.
Vision is not evidence
Founders need a vision large enough to justify the years of work ahead. Investors need to understand how an early product could become a consequential company. But the vision and the next proof perform different jobs.
The vision explains why success matters.
The death variable explains what must become true for success to remain possible.
Confusing them creates a familiar pattern. The company raises money around a large future, completes many activities and reaches the end of the round with the decisive uncertainty still unresolved. It has hired, filed patents, built prototypes, signed partnerships and generated attention. The next investor still cannot answer the one question that determines whether the company works.
Activity has increased. Underwritability has not.
This does not always mean the team executed poorly. The company may never have named the uncertainty precisely enough to design the round around it.
A death variable is not a risk register
Every startup faces many risks:
• Technical performance.
• Manufacturing.
• Regulation.
• Customer adoption.
• Hiring.
• Supply chain.
• Financing.
• Competition.
Listing them is useful and insufficient.
A risk register asks what could go wrong. The death-variable question asks which uncertainty is currently upstream of the others.
If a navigation system cannot maintain acceptable drift under denial, the early sales plan is not the decisive risk. If a chip cannot reach usable package yield, distribution cannot rescue it. If an industrial robot requires constant human intervention, a large pipeline may increase service burden rather than establish product-market fit. If a biological product works in controlled samples but not in the target application, manufacturing scale is premature.
At a given moment, one variable often determines whether several downstream questions are worth asking.
Five kinds of death variable
The death variable can sit at different layers of the company.
Scientific
Does the underlying phenomenon produce the required effect reproducibly?
Examples might include biological activity, material performance, sensitivity, energy density or a physical conversion efficiency.
System
Does the capability survive integration and the relevant operating environment?
The failure may arise from drift, contamination, thermal management, software integration, false positives, duty cycle or interaction with surrounding equipment.
Acceptance
Can the company produce the evidence required by the buyer, regulator or qualification authority?
The technology may work while the product remains outside the decision system.
Economic
Does the complete delivered system produce viable economics after yield, installation, service, warranty, working capital and failure costs?
A product can cross the technical gates and die at the economic one.
Financing
Can the company survive long enough to reach the next proof without relying on capital structurally unsuited to the risk?
This is not merely “runway.” A company can have cash and still possess no credible route to finance the factory, trial, fleet or qualification cycle required by its model.
These categories help locate the variable. They do not remove the need to state it as a measurable claim.
Turn the variable into a threshold
“Manufacturing is our biggest risk” is not yet a death variable.
The statement must become specific enough to test.
A useful formulation contains:
+ threshold
+ operating condition
+ time boundary
+ accepting authority
For example:
below the buyer's economic threshold
across a representative production shift
for a sustained test period
accepted by the operating team responsible for deployment
Or:
above the level required for target gross margin
at the intended production process
across repeated batches
verified by the manufacturing and customer-quality teams
The exact numbers belong to the company and buyer. The form prevents vague progress from replacing decisive evidence.
Find the variable from the buyer backwards
The death variable should not be chosen only by asking what is technically difficult.
Technical teams naturally focus on the problem closest to their work. The buyer may reject the product for a different reason.
I prefer to work backwards:
1. What outcome does the buyer require?
2. What failure would make adoption irresponsible or uneconomic?
3. Which measurement reveals that failure earliest?
4. What threshold changes the buyer's decision?
5. Can the company produce credible evidence within its capital and time constraints?
This approach often reveals that the death variable is not the headline technology.
A robot's core autonomy may be impressive while intervention economics kill the deployment. A material may reach the desired laboratory property while qualification time and process variability kill the company. A sensor may detect the target while false-positive history prevents operational use. A thermal system may reach peak efficiency while seasonal performance and service cost destroy the delivered economics.
The death variable sits where the promise meets the decision.
Beware the attractive proxy
Deeptech companies often measure what is available before they can measure what is decisive.
Publications, patents, prototype demonstrations, accuracy on a selected dataset, letters of intent, pilot count and total pipeline can all be legitimate evidence. They become dangerous when used as proxies for a different claim.
A patent does not establish manufacturability.
A demonstration does not establish qualification.
A pilot does not establish repeat demand.
A letter of intent does not establish willingness to purchase at the required economics.
A signed customer does not establish a reusable product if every deployment is bespoke.
The test is simple:
If this metric improves, does the decisive uncertainty actually shrink?
If the answer is unclear, the metric may describe motion rather than progress.
Design the decisive experiment
Once the death variable is named, the company should design the smallest credible experiment capable of changing the decision.
“Smallest” does not mean cheap or easy. In deeptech, the decisive experiment may require an expensive prototype, a long field test, a manufacturing run or a regulated study. It means the experiment is no broader than necessary to settle the uncertainty.
A strong experiment defines:
• The claim being tested.
• The threshold for success.
• The relevant operating conditions.
• The data required.
• The party that must trust the result.
• The failure interpretation.
• The decision that follows each outcome.
The final point matters. A test without a pre-agreed decision can produce endless interpretation. The team should know beforehand what success unlocks, what partial success changes and what failure ends or redirects.
This is where vulnerability becomes operational rather than rhetorical. The founder has to name the evidence that could prove the current plan wrong.
A company can have more than one death variable sequentially
Calling something “the” death variable can sound as though the company has only one existential risk forever.
It does not.
The dominant uncertainty moves as evidence accumulates.
↓
Does it survive the relevant environment?
↓
Will the authority qualify it?
↓
Can it be produced repeatedly?
↓
Do the delivered economics work?
When one gate is crossed, the next variable becomes visible.
This is a sign of progress. The problem is not that uncertainty remains. The problem is allowing the company to carry the same unresolved uncertainty through several rounds while changing the story around it.
The founder and investor may see different variables
The founder often has access to technical details the investor cannot fully observe. The investor may see capital, market and governance risks that the founder experiences as secondary.
The purpose of the death variable is not to declare one perspective correct. It is to make the disagreement inspectable.
A founder may believe a technical result is nearly certain and consider customer qualification the real challenge. An investor may believe the technical claim still depends on non-representative conditions. The useful conversation is not “Do you believe in the company?” It is:
• Which uncertainty do we disagree about?
• What evidence would resolve it?
• How much will that evidence cost?
• How long will it take?
• Who will accept it?
This turns conviction into an underwriting discussion.
The death variable and company design
The same technology can have different death variables depending on the company's strategic position.
A component supplier may need to prove compatibility and design-in economics. A complete-system challenger may need to prove integration, service and the buyer's full operating outcome. The enabler's technical requirement may be narrower, but its substitutability and bargaining power may become the strategic death variable.
This is why the death variable comes after the company has chosen where it will sit and which acceptance gate it is trying to cross.
The company must know which promise it is taking responsibility for before it can know which proof can kill or validate the model.
What a round should leave behind
The difficult middle should leave the company with more than elapsed time and spent capital. Each gate should create evidence, knowledge or permission that the company can carry forward.
A financing round should do the same.
When the money is spent, the company should possess something it did not possess before:
• A technical option established.
• A death variable retired.
• A qualification accepted.
• A manufacturing process repeated.
• A customer outcome demonstrated.
• A capital-intensive asset made financeable by contracted cash flow.
The round should not be judged only by how long it extends runway. It should be judged by whether it changes what the company is known, trusted and financeable to do.
Once the death variable is named, the question becomes: which kind of capital should buy the proof?
Questions I now ask
1. If the category words are removed, what can actually kill the company?
2. Which uncertainty is upstream of the others today?
3. Is the death variable scientific, systemic, acceptance-related, economic or financial?
4. What measurable threshold determines success?
5. Under which conditions must the threshold be met?
6. Who must accept the evidence?
7. Which attractive metrics are merely proxies?
8. What is the smallest credible experiment that changes the decision?
9. What will happen after success, partial success or failure?
10. What new death variable becomes visible if this one is retired?
The vision tells me why the company could matter.
The death variable tells me what must become true next.